The first drug targeting the cause of Huntington’s disease was safe and well-tolerated in its first human. It successfully lowered the level of the harmful huntingtin protein the nervous system.
As a clinician you get first-hand experience of the benefits, but also limitations, of existing treatments, and naturally identify questions that can often be answered through research.
We are delighted to announce that Thabitha Charles, Senior Clinical Research Nurse at The Manchester Heart Centre, is the overall winner of the Nursing & Midwifery GEM Award in the category of PRIDE
MREH is trialling gene therapy, in collaboration with Saint Mary’s Hospital, for patients with a rare genetic eye condition, x-linked retinitis pigmentosa (XLRP).
More than 40,700 participants were given access to new and better treatments through participation in clinical research in Greater Manchester in the past year, according to figures published today.
The research team at the NIHR Manchester Clinical Research Facility came 3rd in the Trust Wide Brilliant Basics initiative for their creative notice board display.